Q4 2019 Holdings
Filed 2020-02-05 | 9 holdings | $167.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $59.3M | 2,362,286 | 35.4% |
| Arvinas, Inc.(ARVN) | COM | 04335A105 | $56.6M | 1,378,423 | 33.8% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $51.3M | 3,669,263 | 30.6% |
| Aprea Therapeutics, Inc. | COM | 03836J102 | $130.9K | 2,852,654 | 0.1% |
| Homology Medicines, Inc. | COM | 438083107 | $114.6K | 5,535,919 | 0.1% |
| Ideaya Biosciences, Inc.(IDYA) | COM | 45166A102 | $26.0K | 3,463,066 | 0.0% |
| scPharmaceuticals Inc.(SCPH) | COM | 810648105 | $18.4K | 3,253,440 | 0.0% |
| Cidara Therapeutics, Inc. | COM | 171757107 | $7.7K | 2,006,511 | 0.0% |
| Viveve Medical, Inc. | COM | 92852W303 | $10 | 8,078 | 0.0% |